REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 85 filers reported holding REGULUS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $13,000 | -7.1% | 20,000 | 0.0% | 0.00% | – |
| Q1 2018 | $14,000 | -33.3% | 20,000 | 0.0% | 0.00% | – |
| Q4 2017 | $21,000 | -16.0% | 20,000 | 0.0% | 0.00% | – |
| Q3 2017 | $25,000 | +25.0% | 20,000 | 0.0% | 0.00% | – |
| Q2 2017 | $20,000 | -39.4% | 20,000 | 0.0% | 0.00% | – |
| Q1 2017 | $33,000 | -26.7% | 20,000 | 0.0% | 0.00% | – |
| Q4 2016 | $45,000 | -72.7% | 20,000 | -60.0% | 0.00% | – |
| Q3 2016 | $165,000 | -43.1% | 50,000 | -50.0% | 0.00% | – |
| Q2 2016 | $290,000 | -16.4% | 100,000 | +100.0% | 0.00% | -100.0% |
| Q1 2016 | $347,000 | -20.4% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $436,000 | +33.3% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $327,000 | -73.0% | 50,000 | -54.7% | 0.00% | -50.0% |
| Q2 2015 | $1,210,000 | -14.5% | 110,413 | +32.1% | 0.00% | -33.3% |
| Q1 2015 | $1,416,000 | – | 83,597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |